Literature DB >> 24274904

Hand function and quality of life in children with epidermolysis bullosa.

Emily A Eismann1, Anne W Lucky, Roger Cornwall.   

Abstract

Patient-reported outcomes are becoming increasingly important to clinical care. Epidermolysis bullosa (EB), a rare genetic skin disorder, can result in severe hand impairment, but parent and patient perceptions of hand function have never been assessed. This study aimed to quantify parent- and patient-reported hand function and assess its relationship with quality of life (QOL) in children with EB. This cross-sectional study included children with EB treated at an interdisciplinary EB center. Hospital records were searched for demographic characteristics and medical history. Eligible families were invited to complete two surveys by mail or telephone. The ABILHAND-Kids questionnaire assessed manual hand ability for 21 functions. The Quality of Life in Epidermolysis Bullosa questionnaire assessed EB-related QOL. Hand function and QOL of various subtypes were compared using Mann-Whitney tests. Seventy-one parents and patients ages 2 to 18 years with EB from 20 states in the United States completed questionnaires. Children with recessive dystrophic EB reported the worst hand function and QOL. Bimanual functions involving finger mobility were the most challenging for all EB subtypes. QOL was highly related to the degree of hand function, being correlated with 20 of the 21 individual hand functions and most associated with the ability to perform unimanual functions. Parent- and patient-reported hand function can be measured in children with EB using the ABILHAND-Kids questionnaire. Hand impairment is strongly associated with worse QOL, probably due to difficulty performing daily activities. The effect of interventions such as hand surgery could be prospectively evaluated using this questionnaire.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24274904     DOI: 10.1111/pde.12262

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  10 in total

1.  Evaluation of Treatments for Pruritus in Epidermolysis Bullosa.

Authors:  Christina Danial; Rasidat Adeduntan; Emily S Gorell; Anne W Lucky; Amy S Paller; Anna L Bruckner; Elena Pope; Kimberly D Morel; Moise L Levy; Shufeng Li; Elaine S Gilmore; Alfred T Lane
Journal:  Pediatr Dermatol       Date:  2014-12-29       Impact factor: 1.588

2.  Use of multivariate linear regression and support vector regression to predict functional outcome after surgery for cervical spondylotic myelopathy.

Authors:  Haydn Hoffman; Sunghoon I Lee; Jordan H Garst; Derek S Lu; Charles H Li; Daniel T Nagasawa; Nima Ghalehsari; Nima Jahanforouz; Mehrdad Razaghy; Marie Espinal; Amir Ghavamrezaii; Brian H Paak; Irene Wu; Majid Sarrafzadeh; Daniel C Lu
Journal:  J Clin Neurosci       Date:  2015-06-23       Impact factor: 1.961

3.  A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex.

Authors:  Jodi Y So; Shivali Fulchand; Christine Y Wong; Shufeng Li; Jaron Nazaroff; Emily S Gorell; Mark P de Souza; Dedee F Murrell; Joyce M Teng; Albert S Chiou; Jean Y Tang
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

4.  Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study).

Authors:  Amy S Paller; John Browning; Milos Nikolic; Christine Bodemer; Dedee F Murrell; Willistine Lenon; Eva Krusinska; Allen Reha; Hjalmar Lagast; Jay A Barth
Journal:  Orphanet J Rare Dis       Date:  2020-06-23       Impact factor: 4.123

Review 5.  Occupational therapy for epidermolysis bullosa: clinical practice guidelines.

Authors:  Jennifer M Chan; Amy Weisman; Alex King; Susan Maksomski; Carrissa Shotwell; Claire Bailie; Helen Weaver; Rebecca Bodan; Estrella Guerrero; Matija Zmazek; Phuong Khuu
Journal:  Orphanet J Rare Dis       Date:  2019-06-07       Impact factor: 4.123

Review 6.  A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.

Authors:  Jean Yuh Tang; M Peter Marinkovich; Eleanor Lucas; Emily Gorell; Albert Chiou; Ying Lu; Jodie Gillon; Dipen Patel; Dan Rudin
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

7.  Transcultural Validation of a Spanish Version of the Quality of Life in Epidermolysis Bullosa Questionnaire.

Authors:  Alvaro Rafael Villar Hernández; Fernando Molero Alonso; Álvaro Jesús Aguado Marín; Manuel Posada de la Paz
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

8.  Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study.

Authors:  Dedee F Murrell; Amy S Paller; Christine Bodemer; John Browning; Milos Nikolic; Jay A Barth; Hjalmar Lagast; Eva Krusinska; Allen Reha
Journal:  Orphanet J Rare Dis       Date:  2020-07-21       Impact factor: 4.123

9.  Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study.

Authors:  Valeria Prada; S Schizzi; I Poggi; L Mori; C Gemelli; M Hamedani; S Accogli; G Maggi; M Grandis; G L Mancardi; A Schenone
Journal:  J Neurol Neurophysiol       Date:  2018-07-30

Review 10.  Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the Clinician.

Authors:  Jessica J Padniewski; Rob L Shaver; Brittney Schultz; David R Pearson
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.